Scientists Bioengineer Photosynthesis in the Eyes to Treat Dry Eye Disease

Key Points:

• Researchers have developed a novel approach by inserting nanoscale light-harvesting particles derived from spinach chloroplasts, called LEAF, into mammalian eye cells to combat dry eye disease through light-powered chemical generation.
• LEAF particles absorb light to restore intracellular NADPH, a molecule that helps cells manage oxidative stress and inflammation, thereby aiding the eye in fighting dry eye disease symptoms.
• This technology mimics the limited photosynthetic ability seen in sacoglossan sea slugs but repurposes it to generate therapeutic molecules rather than food, using ambient light without external power sources.
• While promising as a potential eye drop treatment, LEAF remains experimental, with significant safety questions regarding immune response, longevity in tissues, and effects of varied real-world light exposure still to be addressed.
• The study represents a groundbreaking proof-of-concept that plant photosynthetic machinery can be functionally integrated into mammalian tissue, offering a novel therapeutic strategy distinct from conventional anti-inflammatory drugs.